Sepsis Diagnostics Market Size, Share & Trends Analysis Report By Product (Assay Kits & Reagents, Blood Culture Media), By Technology (Microbiology, Immunoassays), By Pathogen, By Testing, By Method, By End-usse, By Region, And Segment Forecasts, 2025 - 2030
This report can be delivered to the clients within Immediate
Sepsis Diagnostics Market Growth & Trends
The global sepsis diagnostics market size is expected t%li%reach USD 1.82 billion by 2030, registering a CAGR of 8.09% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected t%li%propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response t%li%pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads t%li%prolonged hospitalization.
According t%li%the WHO, around 30 million people are estimated t%li%be affected by this disease every year. The NCBI stated that the largest number of this condition have been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected t%li%facilitate market growth over the forecast period.
In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens. The COVID-19 pandemic affected the growth of diagnostics products for sepsis in a moderately positive way. The worldwide spread of Coronavirus and the arising instances of sepsis among COVID-19 patients are probably going t%li%expand the interest for fast detection, speeding up the use of instruments, reagents, and assay kits for recognition of sepsis. Pandemic-induced lockdown and other restrictions made individuals delay going through wellbeing checkups, influencing the number of tests performed and reagent deals.
The pandemic has featured the risk upon elders, wh%li%are more defenseless t%li%complications, including intense respiratory distress condition, typically because of pneumonia, which builds the risk of creating sepsis. This has created a need for the early detection of sepsis among patients with COVID-19. Symptoms of sepsis, such as multiorgan injuries, develop in around 2.0 t%li%5.0% of COVID-19 cases 8 t%li%10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. T%li%manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm t%li%detect sepsis in patients with COVID-19.
Sepsis Diagnostics Market Report Highlights
Sepsis Diagnostics Market Growth & Trends
The global sepsis diagnostics market size is expected t%li%reach USD 1.82 billion by 2030, registering a CAGR of 8.09% from 2025 t%li%2030, according t%li%a new report by Grand View Research, Inc. The high prevalence of sepsis, the introduction of technologically advanced diagnostic systems, and increasing government initiatives are expected t%li%propel market growth over the forecast period. Sepsis is a bloodstream disease that occurs as a result of a response t%li%pathogenic microorganisms present in the blood. Patients suffering from this disease experience severe inflammation, which leads t%li%prolonged hospitalization.
According t%li%the WHO, around 30 million people are estimated t%li%be affected by this disease every year. The NCBI stated that the largest number of this condition have been observed in the youngest and oldest age groups. Thus, there is a rising need for the early diagnosis of this disease. The WHO reported that every year, 1.2 million children and 3 million newborns are affected by this disease across the world. This has further boosted the demand for its diagnostic tools for quick results and improved patient outcomes. Increasing regulatory approval and the introduction of technologically advanced diagnostic solutions for sepsis are expected t%li%facilitate market growth over the forecast period.
In May 2018, T2 Biosystems, Inc., a U.S.-based emerging diagnostic solutions company, received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens. The COVID-19 pandemic affected the growth of diagnostics products for sepsis in a moderately positive way. The worldwide spread of Coronavirus and the arising instances of sepsis among COVID-19 patients are probably going t%li%expand the interest for fast detection, speeding up the use of instruments, reagents, and assay kits for recognition of sepsis. Pandemic-induced lockdown and other restrictions made individuals delay going through wellbeing checkups, influencing the number of tests performed and reagent deals.
The pandemic has featured the risk upon elders, wh%li%are more defenseless t%li%complications, including intense respiratory distress condition, typically because of pneumonia, which builds the risk of creating sepsis. This has created a need for the early detection of sepsis among patients with COVID-19. Symptoms of sepsis, such as multiorgan injuries, develop in around 2.0 t%li%5.0% of COVID-19 cases 8 t%li%10 days post-hospitalization, based on the estimates of the Global Sepsis Alliance. T%li%manage this situation, the Biomedical Advanced Research and Development Authority, in May 2020, extended its partnership with Beckman Coulter for the development of a digital algorithm t%li%detect sepsis in patients with COVID-19.
Sepsis Diagnostics Market Report Highlights
- Based on product, blood culture media dominated the market in 2024 with a revenue share of more than 38.90%, as blood culture is considered t%li%be the most cost-effective and convenient mode of testing.
- The microbiology technology segment dominated the global market in 2024 and accounted for the largest share of more than 48.77% of the overall revenue.
- Bacterial segment held the largest revenue share of 86.22% in 2024 and is anticipated t%li%maintain its lead over the forecast period owing t%li%the rise in cases of bacterial sepsis, higher occurrence of hospital-transmitted infections, and rising number of surgical procedures conducted.
- The conventional diagnostics segment held the largest revenue share of 57.12% of the sepsis diagnostics industry in 2024.
- The hospital and clinics segment held the largest revenue share of 79.42% in 2024, owing t%li%an increase in hospitalization.
- The laboratory testing segment dominated the market in 2024 in terms of revenue share. Advancements in laboratory testing have made it easier and faster t%li%detect sepsis, leading t%li%better outcomes for patients.
- North America sepsis diagnostics market dominated globally in 2024 and accounted for the largest revenue share of more than 43.9%.
Table Of Contents
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation And Scope
1.2 Market Definitions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database:
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach: Commodity Flow Approach
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Abbreviations
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.11.4 Objective
1.11.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Product And Technology Snapshot
2.3 Pathogen And Testing Snapshot
2.4 Method And End Use Snapshot
2.5 Competitive Landscape Snapshot
CHAPTER 3 SEPSIS DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increase In Prevalence Of Sepsis
3.2.1.2 Rise In Incidence Of Hospital-Acquired Infections
3.2.1.3 Increase In The Number Of Pneumonia Cases
3.2.1.4 Approval And Launch Of Advanced Sepsis Diagnostic System
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Automated Diagnostic Instruments
3.2.2.2 Lack Of Awareness About Sepsis
3.2.3 Industry Challenges
3.2.3.1 Scientific And Clinical Challenges Associated With Sepsis
3.3 Sepsis Diagnostics: Market Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Sepsis Diagnostics – Macroeconomic Analysis
CHAPTER 4 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
4.1 Sepsis Diagnostics Market: Product Movement Analysis
4.2 Sepsis Diagnostics Market Estimates & Forecast, By Product (USD Million)
4.2.1 Instrument
4.2.2 Blood Culture Media
4.2.3 Assay Kits And Reagents
4.2.4 Software
CHAPTER 5 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
5.1 Sepsis Diagnostics Market: Technology Movement Analysis
5.2 Sepsis Diagnostics Market Estimates & Forecast, By Technology (USD Million)
5.2.1 Microbiology
5.2.2 Molecular Diagnostics
5.2.2.1 Polymerase Chain Reaction (Pcr)
5.2.2.2 Dna Microarrays
5.2.2.3 Syndromic Panel Testing
5.2.2.4 Others
5.2.3 Immunoassays
5.2.4 Flow Cytometry
5.2.5 Others
CHAPTER 6 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY PATHOGEN, 2018 - 2030 (USD MILLION)
6.1 Sepsis Diagnostics Market: Pathogen Movement Analysis
6.2 Sepsis Diagnostics Market Estimates & Forecast, By Pathogen (USD Million)
6.2.1 Bacterial Sepsis
6.2.1.1 Gram-Positive Bacteria
6.2.1.2 Gram-Negative Bacteria
6.2.2 Fungal Sepsis
6.2.3 Viral Sepsis
6.2.4 Others
CHAPTER 7 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY TESTING, 2018 - 2030 (USD MILLION)
7.1 Sepsis Diagnostics Market: Testing Movement Analysis
7.2 Sepsis Diagnostics Market Estimates & Forecast, By Testing (USD Million)
7.2.1 Laboratory Testing
7.2.2 Point-Of-Care Testing
CHAPTER 8 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY METHOD, 2018 - 2030 (USD MILLION)
8.1 Sepsis Diagnostics Market: Method Movement Analysis
8.2 Sepsis Diagnostics Market Estimates & Forecast, By Method (USD Million)
8.2.1 Automated Diagnostics
8.2.2 Conventional Diagnostics
CHAPTER 9 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION)
9.1 Sepsis Diagnostics Market: End Use Movement Analysis
9.2 Sepsis Diagnostics Market Estimates & Forecast, By End Use (USD Million)
9.2.1 Hospitals & Clinics
9.2.2 Pathology & Reference Laboratories
9.2.3 Research Institutes And Others
CHAPTER 10 SEPSIS DIAGNOSTIC MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS, BY PRODUCT, BY TECHNOLOGY, BY PATHOGEN, BY TESTING, BY METHOD, & BY END USE
10.1 Sepsis Diagnostic Market: Regional Outlook
10.2 North America
10.2.1 North America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.2.1.1 Regulatory Framework
10.2.1.2 Reimbursement Scenario
10.2.2 U.S.
10.2.2.1 Key Country Dynamics
10.2.2.2 U.S. Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.2.2.3 Market & Competitive Scenario
10.2.3 Canada
10.2.3.1 Key Country Dynamics
10.2.3.2 Canada Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.2.3.3 Market And Competitive Scenario
10.3 Europe
10.3.1 Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.1.1 Regulatory Framework
10.3.1.2 Reimbursement Scenario
10.3.2 Uk
10.3.2.1 Key Country Dynamics
10.3.2.2 Uk Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.2.3 Market & Competitive Scenario
10.3.3 Germany
10.3.3.1 Key Country Dynamics
10.3.3.2 Germany Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.3.3 Market & Competitive Scenario
10.3.4 France
10.3.4.1 Key Country Dynamics
10.3.4.2 France Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.4.3 Market & Competitive Scenario
10.3.5 Spain
10.3.5.1 Key Country Dynamics
10.3.5.2 Spain Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.5.3 Market & Competitive Scenario
10.3.6 Italy
10.3.6.1 Key Country Dynamics
10.3.6.2 Italy Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.6.3 Market & Competitive Scenario
10.3.7 Denmark
10.3.7.1 Key Country Dynamics
10.3.7.2 Denmark Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.7.3 Market & Competitive Scenario
10.3.8 Sweden
10.3.8.1 Key Country Dynamics
10.3.8.2 Sweden Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.8.3 Market & Competitive Scenario
10.3.9 Norway
10.3.9.1 Key Country Dynamics
10.3.9.2 Norway Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.9.3 Market & Competitive Scenario
10.3.10 Russia
10.3.10.1 Key Country Dynamics
10.3.10.2 Russia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.10.3 Market & Competitive Scenario
10.3.10.4 Rest Of Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.1.1 Regulatory Framework
10.4.1.2 Reimbursement Scenario
10.4.2 Japan
10.4.2.1 Key Country Dynamics
10.4.2.2 Japan Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.2.3 Market And Competitive Scenario
10.4.3 China
10.4.3.1 Key Country Dynamics
10.4.3.2 China Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.3.3 Market And Competitive Scenario
10.4.4 India
10.4.4.1 Key Country Dynamics
10.4.4.2 India Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.4.3 Market And Competitive Scenario
10.4.5 Australia
10.4.5.1 Key Country Dynamics
10.4.5.2 Australia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.5.3 Market And Competitive Scenario
10.4.6 Thailand
10.4.6.1 Key Country Dynamics
10.4.6.2 Thailand Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.6.3 Market And Competitive Scenario
10.4.7 South Korea
10.4.7.1 Key Country Dynamics
10.4.7.2 South Korea Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.7.3 Market And Competitive Scenario
10.4.8 Singapore
10.4.8.1 Key Country Dynamics
10.4.8.2 Singapore Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.8.3 Market And Competitive Scenario
10.4.8.4 Rest Of Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5 Latin America
10.5.1 Latin America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.1.1 Regulatory Framework
10.5.1.2 Reimbursement Scenario
10.5.2 Brazil
10.5.2.1 Key Country Dynamics
10.5.2.2 Brazil Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.2.3 Market And Competitive Scenario
10.5.3 Mexico
10.5.3.1 Key Country Dynamics
10.5.3.2 Mexico Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.3.3 Market And Competitive Scenario
10.5.4 Argentina
10.5.4.1 Key Country Dynamics
10.5.4.2 Argentina Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.4.3 Market And Competitive Scenario
10.5.4.4 Rest Of Latam Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6 MEA
10.6.1 MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.1.1 Regulatory Framework
10.6.1.2 Reimbursement Scenario
10.6.2 South Africa
10.6.2.1 Key Country Dynamics
10.6.2.2 South Africa Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.2.3 Market And Competitive Scenario
10.6.3 Saudi Arabia
10.6.3.1 Key Country Dynamics
10.6.3.2 Saudi Arabia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.3.3 Market And Competitive Scenario
10.6.4 UAE
10.6.4.1 Key Country Dynamics
10.6.4.2 UAE Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.4.3 Competitive Scenario
10.6.5 Kuwait
10.6.5.1 Key Country Dynamics
10.6.5.2 Kuwait Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.5.3 Market And Competitive Scenario
10.6.5.4 Rest Of MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 11 COMPETITIVE LANDSCAPE
11.1 Company Categorization
11.2 Company Market Positioning
11.2.1 Market Leaders
11.2.1.1 Sepsis Diagnostics Market Share Analysis, 2024
11.4 Company Profiles
11.4 Company Profiles
11.4.1 Biomйrieux Sa
11.4.1.1 Company Overview
11.4.1.2 Financial Performance
11.4.1.3 Product Benchmarking
11.4.1.4 Strategic Initiatives
11.4.2 Becton, Dickinson And Company (Bd)
11.4.2.1 Company Overview
11.4.2.2 Financial Performance
11.4.2.3 Product Benchmarking
11.4.2.4 Strategic Initiatives
11.4.3 Thermo Fisher Scientific, Inc.
11.4.3.1 Company Overview
11.4.3.2 Financial Performance
11.4.3.3 Product Benchmarking
11.4.3.4 Strategic Initiatives
11.4.4 F. Hoffmann-La Roche
11.4.4.1 Company Overview
11.4.4.2 Financial Performance
11.4.4.3 Product Benchmarking
11.4.4.4 Strategic Initiatives
11.4.5 Luminex Corporation
11.4.5.1 Company Overview
11.4.5.2 Financial Performance
11.4.5.3 Product Benchmarking
11.4.5.4 Strategic Initiatives
11.4.6 Danaher
11.4.6.1 Cepheid
11.4.6.1.1 Company Overview
11.4.6.1.2 Financial Performance
11.4.6.1.3 Product Benchmarking
11.4.6.1.4 Strategic Initiatives
11.4.6.2 Beckman Coulter, Inc.
11.4.6.2.1 Company Overview
11.4.6.2.2 Financial Performance
11.4.6.2.3 Product Benchmarking
11.4.6.2.4 Strategic Initiatives
11.4.7 Luminex Corporation
11.4.7.1 Company Overview
11.4.7.2 Financial Performance
11.4.7.3 Product Benchmarking
11.4.7.4 Strategic Initiatives
11.4.8 Bruker Corporation
11.4.8.1 Company Overview
11.4.8.2 Financial Performance
11.4.8.3 Product Benchmarking
11.4.8.4 Strategic Initiatives
11.4.9 Amara Health Analytics
11.4.9.1 Company Overview
11.4.9.2 Financial Performance
11.4.9.3 Product Benchmarking
11.4.9.4 Strategic Initiatives
11.4.10 Cepheid
11.4.10.1 Company Overview
11.4.10.2 Financial Performance
11.4.10.3 Product Benchmarking
11.4.10.4 Strategic Initiatives
11.4.11 Beckman Coulter, Inc.
11.4.11.1 Company Overview
11.4.11.2 Financial Performance
11.4.11.4 Product Benchmarking
11.4.11.4 Strategic Initiatives
11.4.12 Bruker Corporation
11.4.12.1 Company Overview
11.4.12.2 Financial Performance
11.4.12.3 Product Benchmarking
11.4.12.4 Strategic Initiatives
11.4.13 Immunexpress, Inc.
11.4.13.1 Company Overview
11.4.13.2 Financial Performance
11.4.13.3 Product Benchmarking
11.4.13.4 Strategic Initiatives
11.4.14 Koninklijke Philips N.V.
11.4.14.1 Company Overview
11.4.14.2 Financial Performance
11.4.14.3 Product Benchmarking
11.4.14.4 Strategic Initiatives
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation And Scope
1.2 Market Definitions
1.2.1 Estimates And Forecast Timeline
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Purchased Database:
1.4.2 Gvr’s Internal Database
1.4.3 Secondary Sources
1.4.4 Primary Research
1.4.5 Details Of Primary Research
1.5 Information Or Data Analysis
1.5.1 Data Analysis Models
1.6 Market Formulation & Validation
1.7 Model Details
1.7.1 Commodity Flow Analysis
1.7.1.1 Approach: Commodity Flow Approach
1.8 Research Assumptions
1.9 List Of Secondary Sources
1.10 List Of Abbreviations
1.11 Objectives
1.11.1 Objective
1.11.2 Objective
1.11.4 Objective
1.11.4 Objective
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Snapshot
2.2 Product And Technology Snapshot
2.3 Pathogen And Testing Snapshot
2.4 Method And End Use Snapshot
2.5 Competitive Landscape Snapshot
CHAPTER 3 SEPSIS DIAGNOSTICS MARKET VARIABLES, TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Related/Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increase In Prevalence Of Sepsis
3.2.1.2 Rise In Incidence Of Hospital-Acquired Infections
3.2.1.3 Increase In The Number Of Pneumonia Cases
3.2.1.4 Approval And Launch Of Advanced Sepsis Diagnostic System
3.2.2 Market Restraint Analysis
3.2.2.1 High Cost Of Automated Diagnostic Instruments
3.2.2.2 Lack Of Awareness About Sepsis
3.2.3 Industry Challenges
3.2.3.1 Scientific And Clinical Challenges Associated With Sepsis
3.3 Sepsis Diagnostics: Market Analysis Tools
3.3.1 Porter’s Analysis
3.3.2 Sepsis Diagnostics – Macroeconomic Analysis
CHAPTER 4 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY PRODUCT, 2018 - 2030 (USD MILLION)
4.1 Sepsis Diagnostics Market: Product Movement Analysis
4.2 Sepsis Diagnostics Market Estimates & Forecast, By Product (USD Million)
4.2.1 Instrument
4.2.2 Blood Culture Media
4.2.3 Assay Kits And Reagents
4.2.4 Software
CHAPTER 5 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY TECHNOLOGY, 2018 - 2030 (USD MILLION)
5.1 Sepsis Diagnostics Market: Technology Movement Analysis
5.2 Sepsis Diagnostics Market Estimates & Forecast, By Technology (USD Million)
5.2.1 Microbiology
5.2.2 Molecular Diagnostics
5.2.2.1 Polymerase Chain Reaction (Pcr)
5.2.2.2 Dna Microarrays
5.2.2.3 Syndromic Panel Testing
5.2.2.4 Others
5.2.3 Immunoassays
5.2.4 Flow Cytometry
5.2.5 Others
CHAPTER 6 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY PATHOGEN, 2018 - 2030 (USD MILLION)
6.1 Sepsis Diagnostics Market: Pathogen Movement Analysis
6.2 Sepsis Diagnostics Market Estimates & Forecast, By Pathogen (USD Million)
6.2.1 Bacterial Sepsis
6.2.1.1 Gram-Positive Bacteria
6.2.1.2 Gram-Negative Bacteria
6.2.2 Fungal Sepsis
6.2.3 Viral Sepsis
6.2.4 Others
CHAPTER 7 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY TESTING, 2018 - 2030 (USD MILLION)
7.1 Sepsis Diagnostics Market: Testing Movement Analysis
7.2 Sepsis Diagnostics Market Estimates & Forecast, By Testing (USD Million)
7.2.1 Laboratory Testing
7.2.2 Point-Of-Care Testing
CHAPTER 8 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY METHOD, 2018 - 2030 (USD MILLION)
8.1 Sepsis Diagnostics Market: Method Movement Analysis
8.2 Sepsis Diagnostics Market Estimates & Forecast, By Method (USD Million)
8.2.1 Automated Diagnostics
8.2.2 Conventional Diagnostics
CHAPTER 9 SEPSIS DIAGNOSTICS MARKET: SEGMENT ANALYSIS, BY END USE, 2018 - 2030 (USD MILLION)
9.1 Sepsis Diagnostics Market: End Use Movement Analysis
9.2 Sepsis Diagnostics Market Estimates & Forecast, By End Use (USD Million)
9.2.1 Hospitals & Clinics
9.2.2 Pathology & Reference Laboratories
9.2.3 Research Institutes And Others
CHAPTER 10 SEPSIS DIAGNOSTIC MARKET: REGIONAL ESTIMATES AND TREND ANALYSIS, BY PRODUCT, BY TECHNOLOGY, BY PATHOGEN, BY TESTING, BY METHOD, & BY END USE
10.1 Sepsis Diagnostic Market: Regional Outlook
10.2 North America
10.2.1 North America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.2.1.1 Regulatory Framework
10.2.1.2 Reimbursement Scenario
10.2.2 U.S.
10.2.2.1 Key Country Dynamics
10.2.2.2 U.S. Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.2.2.3 Market & Competitive Scenario
10.2.3 Canada
10.2.3.1 Key Country Dynamics
10.2.3.2 Canada Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.2.3.3 Market And Competitive Scenario
10.3 Europe
10.3.1 Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.1.1 Regulatory Framework
10.3.1.2 Reimbursement Scenario
10.3.2 Uk
10.3.2.1 Key Country Dynamics
10.3.2.2 Uk Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.2.3 Market & Competitive Scenario
10.3.3 Germany
10.3.3.1 Key Country Dynamics
10.3.3.2 Germany Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.3.3 Market & Competitive Scenario
10.3.4 France
10.3.4.1 Key Country Dynamics
10.3.4.2 France Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.4.3 Market & Competitive Scenario
10.3.5 Spain
10.3.5.1 Key Country Dynamics
10.3.5.2 Spain Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.5.3 Market & Competitive Scenario
10.3.6 Italy
10.3.6.1 Key Country Dynamics
10.3.6.2 Italy Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.6.3 Market & Competitive Scenario
10.3.7 Denmark
10.3.7.1 Key Country Dynamics
10.3.7.2 Denmark Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.7.3 Market & Competitive Scenario
10.3.8 Sweden
10.3.8.1 Key Country Dynamics
10.3.8.2 Sweden Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.8.3 Market & Competitive Scenario
10.3.9 Norway
10.3.9.1 Key Country Dynamics
10.3.9.2 Norway Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.9.3 Market & Competitive Scenario
10.3.10 Russia
10.3.10.1 Key Country Dynamics
10.3.10.2 Russia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.3.10.3 Market & Competitive Scenario
10.3.10.4 Rest Of Europe Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.1.1 Regulatory Framework
10.4.1.2 Reimbursement Scenario
10.4.2 Japan
10.4.2.1 Key Country Dynamics
10.4.2.2 Japan Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.2.3 Market And Competitive Scenario
10.4.3 China
10.4.3.1 Key Country Dynamics
10.4.3.2 China Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.3.3 Market And Competitive Scenario
10.4.4 India
10.4.4.1 Key Country Dynamics
10.4.4.2 India Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.4.3 Market And Competitive Scenario
10.4.5 Australia
10.4.5.1 Key Country Dynamics
10.4.5.2 Australia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.5.3 Market And Competitive Scenario
10.4.6 Thailand
10.4.6.1 Key Country Dynamics
10.4.6.2 Thailand Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.6.3 Market And Competitive Scenario
10.4.7 South Korea
10.4.7.1 Key Country Dynamics
10.4.7.2 South Korea Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.7.3 Market And Competitive Scenario
10.4.8 Singapore
10.4.8.1 Key Country Dynamics
10.4.8.2 Singapore Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.4.8.3 Market And Competitive Scenario
10.4.8.4 Rest Of Asia Pacific Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5 Latin America
10.5.1 Latin America Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.1.1 Regulatory Framework
10.5.1.2 Reimbursement Scenario
10.5.2 Brazil
10.5.2.1 Key Country Dynamics
10.5.2.2 Brazil Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.2.3 Market And Competitive Scenario
10.5.3 Mexico
10.5.3.1 Key Country Dynamics
10.5.3.2 Mexico Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.3.3 Market And Competitive Scenario
10.5.4 Argentina
10.5.4.1 Key Country Dynamics
10.5.4.2 Argentina Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.5.4.3 Market And Competitive Scenario
10.5.4.4 Rest Of Latam Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6 MEA
10.6.1 MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.1.1 Regulatory Framework
10.6.1.2 Reimbursement Scenario
10.6.2 South Africa
10.6.2.1 Key Country Dynamics
10.6.2.2 South Africa Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.2.3 Market And Competitive Scenario
10.6.3 Saudi Arabia
10.6.3.1 Key Country Dynamics
10.6.3.2 Saudi Arabia Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.3.3 Market And Competitive Scenario
10.6.4 UAE
10.6.4.1 Key Country Dynamics
10.6.4.2 UAE Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.4.3 Competitive Scenario
10.6.5 Kuwait
10.6.5.1 Key Country Dynamics
10.6.5.2 Kuwait Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
10.6.5.3 Market And Competitive Scenario
10.6.5.4 Rest Of MEA Sepsis Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
CHAPTER 11 COMPETITIVE LANDSCAPE
11.1 Company Categorization
11.2 Company Market Positioning
11.2.1 Market Leaders
11.2.1.1 Sepsis Diagnostics Market Share Analysis, 2024
11.4 Company Profiles
11.4 Company Profiles
11.4.1 Biomйrieux Sa
11.4.1.1 Company Overview
11.4.1.2 Financial Performance
11.4.1.3 Product Benchmarking
11.4.1.4 Strategic Initiatives
11.4.2 Becton, Dickinson And Company (Bd)
11.4.2.1 Company Overview
11.4.2.2 Financial Performance
11.4.2.3 Product Benchmarking
11.4.2.4 Strategic Initiatives
11.4.3 Thermo Fisher Scientific, Inc.
11.4.3.1 Company Overview
11.4.3.2 Financial Performance
11.4.3.3 Product Benchmarking
11.4.3.4 Strategic Initiatives
11.4.4 F. Hoffmann-La Roche
11.4.4.1 Company Overview
11.4.4.2 Financial Performance
11.4.4.3 Product Benchmarking
11.4.4.4 Strategic Initiatives
11.4.5 Luminex Corporation
11.4.5.1 Company Overview
11.4.5.2 Financial Performance
11.4.5.3 Product Benchmarking
11.4.5.4 Strategic Initiatives
11.4.6 Danaher
11.4.6.1 Cepheid
11.4.6.1.1 Company Overview
11.4.6.1.2 Financial Performance
11.4.6.1.3 Product Benchmarking
11.4.6.1.4 Strategic Initiatives
11.4.6.2 Beckman Coulter, Inc.
11.4.6.2.1 Company Overview
11.4.6.2.2 Financial Performance
11.4.6.2.3 Product Benchmarking
11.4.6.2.4 Strategic Initiatives
11.4.7 Luminex Corporation
11.4.7.1 Company Overview
11.4.7.2 Financial Performance
11.4.7.3 Product Benchmarking
11.4.7.4 Strategic Initiatives
11.4.8 Bruker Corporation
11.4.8.1 Company Overview
11.4.8.2 Financial Performance
11.4.8.3 Product Benchmarking
11.4.8.4 Strategic Initiatives
11.4.9 Amara Health Analytics
11.4.9.1 Company Overview
11.4.9.2 Financial Performance
11.4.9.3 Product Benchmarking
11.4.9.4 Strategic Initiatives
11.4.10 Cepheid
11.4.10.1 Company Overview
11.4.10.2 Financial Performance
11.4.10.3 Product Benchmarking
11.4.10.4 Strategic Initiatives
11.4.11 Beckman Coulter, Inc.
11.4.11.1 Company Overview
11.4.11.2 Financial Performance
11.4.11.4 Product Benchmarking
11.4.11.4 Strategic Initiatives
11.4.12 Bruker Corporation
11.4.12.1 Company Overview
11.4.12.2 Financial Performance
11.4.12.3 Product Benchmarking
11.4.12.4 Strategic Initiatives
11.4.13 Immunexpress, Inc.
11.4.13.1 Company Overview
11.4.13.2 Financial Performance
11.4.13.3 Product Benchmarking
11.4.13.4 Strategic Initiatives
11.4.14 Koninklijke Philips N.V.
11.4.14.1 Company Overview
11.4.14.2 Financial Performance
11.4.14.3 Product Benchmarking
11.4.14.4 Strategic Initiatives
